Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 17
«Preious | of 4 |
1

Quality Standard Improvement for Rougan Granules

Drug Evaluation, Volume 19, Issue 5,2022, Pages 267-270, doi:10.19939/j.cnki.1672-2809.2022.05.03

2

2161 Cases of Adverse Reactions of Melanoma Associated with Phosphodiesterase-5 Inhibitors

Drug Evaluation, Volume 19, Issue 5,2022, Pages 312-316, doi:10.19939/j.cnki.1672-2809.2022.05.15

4

《药品评价》杂志稿约

Drug Evaluation, Volume 19, Issue 5,2022, Pages 后插1-后插2, doi:10.3969/j.issn.1672-2809.2022.05.017

5

Quality Evaluation of Longdan Xiegan Pills (Water Pills)

Drug Evaluation, Volume 19, Issue 5,2022, Pages 283-286,316, doi:10.19939/j.cnki.1672-2809.2022.05.07

Items 1-5 of 17
«Preious | of 4 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn